Traded Feb 25 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 3, 2026 · Filed Feb 4, 2026
A Calix director sold $633K of Calix shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$632,527
Shares × reported transaction price
6 days after results of Jan 28, 2026, 77 days before results of Apr 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.7% | +0.5% | +2.2% |
| 30 days | +0.6% | +0.1% | +0.5% |
| 90 days | −12.5% | +8.3% | −20.8% |
| 180 days | −22.1% | +13.8% | −35.9% |
Past results only. Not a forecast.
Traded Feb 25 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 25 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 14 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.